Last updated on November 2017

A Multi-Center, Randomized, Double-Blind, Parallel-Group Vehicle Controlled Study To Compare The Efficacy And Safety Of CD5789 50µg/g Cream Versus Vehicle Cream In Subjects With Acne Vulgaris


Brief description of study

A Multi-Center, Randomized, Double-Blind, Parallel-Group Vehicle Controlled Study To Compare The Efficacy And Safety Of CD5789 50µg/g Cream Versus Vehicle Cream In Subjects With Acne Vulgaris

Detailed Study Description

Assessment of the efficacy and safety of CD5789 50µg/g cream applied once daily for 12 weeks in subjects with moderate facial and truncal acne vulgaris.

Clinical Study Identifier: TX15205

.

Contact Investigators or Research Sites near you

Start Over

Please choose location

View all locations

Andrew Frisina

Schweiger Dermatology, PLLC
New York, NY USA
  Connect »